Patterns of Drug-Induced Liver Injury Among Patients Receiving First-Line Anti- Tuberculosis Therapy at a National Referral Centre in Sri Lanka: A Prospective Observational Study

Abstract Background Drug-induced liver injury (DILI) represents a significant complication of anti-tuberculosis therapy (ATT). There is limited evidence on its biochemical patterns and clinical outcomes in Sri Lanka. This study aimed to characterise the biochemical patterns, clinical features, and outcomes of ATT-associated DILI. Methods A prospective observational study was conducted at the National Hospital for Respiratory Diseases, Welisara, Sri Lanka, from January to June 2026. Adults who developed DILI while receiving first-line ATT were consecutively recruited and prospectively followed. Biochemical injury patterns were classified using the R-ratio calculated from alanine aminotransferase and alkaline phosphatase measurements obtained at initial DILI diagnosis. Clinical characteristics, treatment modifications and outcomes were analysed. Results Forty-six patients were included (mean age 58.7 ± 14.8 years; 71.7% male). Mixed-pattern injury was most prevalent (60.9%), followed by hepatocellular (26.1%) and cholestatic (13.0%) patterns. The most frequently reported symptoms were nausea (89.1%), vomiting (69.6%), and fatigue (67.4%). Jaundice was observed in 15.2% of patients and occurred significantly more often in those with cholestatic injury (p = 0.026). No statistically significant associations were found between biochemical patterns and demographic or clinical characteristics. Modification of ATT was necessary in 73.9% of cases, and 93.5% underwent drug rechallenge. Full recovery was achieved in 65.2% of patients, partial recovery in 28.3%, and mortality was 4.3%. Conclusions Mixed-pattern liver injury predominated in this prospective Sri Lankan cohort, in contrast to the hepatocellular predominance reported in several international studies. ATT-associated DILI frequently required treatment modification, illustrating the importance of early recognition, biochemical monitoring and careful drug reintroduction.

Authors

Publication Details

Journal
Research Square
Published
2026-11-14
DOI
https://doi.org/10.21203/rs.3.rs-11509437/v1
Primary Topic
Drug-Induced Hepatotoxicity and Protection
Type
preprint
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
preprint

Patterns of Drug-Induced Liver Injury Among Patients Receiving First-Line Anti- Tuberculosis Therapy at a National Referral Centre in Sri Lanka: A Prospective Observational Study

Eshanth Perera, Piume Ellangage, Kasun Tharaka Maduranga Kriya Badugei, V.U Jayasingha et al.
Research Square
Drug-Induced Hepatotoxicity and Protection
preprint

Patterns of Drug-Induced Liver Injury Among Patients Receiving First-Line Anti- Tuberculosis Therapy at a National Referral Centre in Sri Lanka: A Prospective Observational Study

Eshanth Perera, Piume Ellangage, Kasun Tharaka Maduranga Kriya Badugei, V.U Jayasingha, H.I .M Dissanayaka
preprint en

Abstract

Abstract Background Drug-induced liver injury (DILI) represents a significant complication of anti-tuberculosis therapy (ATT). There is limited evidence on its biochemical patterns and clinical outcomes in Sri Lanka. This study aimed to characterise the biochemical patterns, clinical features, and outcomes of ATT-associated DILI. Methods A prospective observational study was conducted at the National Hospital for Respiratory Diseases, Welisara, Sri Lanka, from January to June 2026. Adults who developed DILI while receiving first-line ATT were consecutively recruited and prospectively followed. Biochemical injury patterns were classified using the R-ratio calculated from alanine aminotransferase and alkaline phosphatase measurements obtained at initial DILI diagnosis. Clinical characteristics, treatment modifications and outcomes were analysed. Results Forty-six patients were included (mean age 58.7 ± 14.8 years; 71.7% male). Mixed-pattern injury was most prevalent (60.9%), followed by hepatocellular (26.1%) and cholestatic (13.0%) patterns. The most frequently reported symptoms were nausea (89.1%), vomiting (69.6%), and fatigue (67.4%). Jaundice was observed in 15.2% of patients and occurred significantly more often in those with cholestatic injury (p = 0.026). No statistically significant associations were found between biochemical patterns and demographic or clinical characteristics. Modification of ATT was necessary in 73.9% of cases, and 93.5% underwent drug rechallenge. Full recovery was achieved in 65.2% of patients, partial recovery in 28.3%, and mortality was 4.3%. Conclusions Mixed-pattern liver injury predominated in this prospective Sri Lankan cohort, in contrast to the hepatocellular predominance reported in several international studies. ATT-associated DILI frequently required treatment modification, illustrating the importance of early recognition, biochemical monitoring and careful drug reintroduction.

Research Square
Drug-Induced Hepatotoxicity and Protection
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon